ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,821Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 15

$524K Total Retail Price of All Prescriptions

Rank: 3 out of 15

399 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 15%.

Schedule Three
Controlled Substances

4% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 9,587 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
WARFARIN SODIUM 507 451 1 1
METOPROLOL TARTRATE 436 422 2 4
LEVOTHYROXINE SODIUM 405 378 3 3
SERTRALINE HCL 378 313 4 5
FUROSEMIDE 330 321 5 2
AMLODIPINE BESYLATE 328 327 6 11
LISINOPRIL 321 304 7 6
SIMVASTATIN 284 241 8 7
TRAMADOL HCL 278 229 9 10
MIRTAZAPINE 271 259 10 12
DONEPEZIL HCL 267 267 11 9
OMEPRAZOLE 241 220 12 8
TRAZODONE HCL 181 166 13 16
ADVAIR DISKUS 173 160 14 24
LANTUS 167 156 15 21
SPIRIVA 167 144 15 22
TAMSULOSIN HCL 147 137 17 29
ATORVASTATIN CALCIUM 147 139 17 23
DIVALPROEX SODIUM 141 138 19 34
RISPERIDONE 132 114 20 15
NAMENDA 129 129 21 17
CITALOPRAM HBR 128 126 22 13
METOPROLOL SUCCINATE 122 117 23 14
POTASSIUM CHLORIDE 106 106 24 19
KLOR-CON M10 101 96 25 62
GABAPENTIN 99 64 26 18
FINASTERIDE 89 71 27 64
CYMBALTA 86 50 28 28
OLANZAPINE 86 86 28 40
PANTOPRAZOLE SODIUM 85 81 30 55
SPIRONOLACTONE 84 84 31 46
FLUOXETINE HCL 78 68 32 50
NYSTATIN 76 44 33 41
HALOPERIDOL 76 76 33 85
PREDNISONE 75 74 35 35
METFORMIN HCL 74 57 36 32
ESCITALOPRAM OXALATE 72 63 37 38
PAROXETINE HCL 71 63 38 46
ISOSORBIDE MONONITRATE ER 67 62 39 26
NYSTOP 67 39 39 88
NITROGLYCERIN PATCH 66 66 41 68
OXYCODONE HCL 63 59 S2 42 25
BACLOFEN 61 16 43 57
ALBUTEROL SULFATE 58 53 44 97
ATENOLOL 56 56 45 33
POLYETHYLENE GLYCOL 3350 56 43 45 20
NOVOLOG 56 38 45 100
CIPROFLOXACIN HCL 54 47 48 53
DIGOXIN 53 53 49 45
KLOR-CON M20 51 51 50 36
GENERLAC 50 31 51 67
FAMOTIDINE 50 34 51 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.